Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2861)
All Articles published online
|
Jul 10, 2011 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Arcaini L, Merli M. Rituximab maintenance in follicular lymphoma patients . World J Clin Oncol 2011; 2(7): 281-288 [PMID: 21773078 DOI: 10.5306/wjco.v2.i7.281] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v2/i7/281.htm |
| Number | Citing Articles |
| 1 |
Andre Goy. Mantle cell lymphoma: continuously improving the odds!. Expert Opinion on Orphan Drugs 2013; 1(12): 1001 doi: 10.1517/21678707.2013.854700
|
| 2 |
Xiaolei Zhou, Jianmin Wang, Jessica Zhang, Catherine Copley-Merriman, Yasuhiro Torigoe, Carolina Reyes, John F. Seymour, Fritz C. Offner, Marek Trneny, Gilles Andre Salles. Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma. Hematology 2015; 20(3): 129 doi: 10.1179/1607845414Y.0000000179
|
| 3 |
Giovanni Carulli, Virginia Ottaviano, Paola Sammuri, Cristiana Domenichini, Valentina Guerri, Martina Rousseau, Eugenio M. Ciancia, Elena Ciabatti, Mario Petrini. Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study. International Journal of Hematology 2015; 102(1): 59 doi: 10.1007/s12185-015-1798-9
|
| 4 |
Amy K. Erbe, Wei Wang, Lakeesha Carmichael, Anna Hoefges, Bartosz Grzywacz, Patrick K. Reville, Erik A. Ranheim, Jacquelyn A. Hank, KyungMann Kim, Songwon Seo, Eneida A. Mendonca, Yiqiang Song, Vaishalee P. Kenkre, Fangxin Hong, Randy D. Gascoyne, Elisabeth Paietta, Sandra J. Horning, Jeffrey S. Miller, Brad Kahl, Paul M. Sondel. Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0538-8
|
| 5 |
M. Makatsori, S. Kiani-Alikhan, A. L. Manson, N. Verma, M. Leandro, N. P. Gurugama, H. J. Longhurst, S. Grigoriadou, M. Buckland, E. Kanfer, S. Hanson, M. A. A. Ibrahim, B. Grimbacher, R. Chee, S. L. Seneviratne. Hypogammaglobulinaemia after rituximab treatment--incidence and outcomes. QJM 2014; 107(10): 821 doi: 10.1093/qjmed/hcu094
|